Moreover, Greve et al. have performed a case-control association study in German, Hungarian, and Polish MS patients and a group of controls to investigate the role of CTLA-4 CT60 and +49A/G polymorphisms [135]. The gene discussed is CTLA4; the disease is myeloid sarcoma.